KBIO (KBIO) has the following price history information. Looking back at KBIO historical stock prices for the last five trading days, on July 31, 2017, KBIO opened at $1.60, traded as high as $1.75 and as low as $1.60, and closed at $1.74. Trading volume was a total of 7.60K shares. On August 01, 2017, KBIO opened at $1.60, traded as high as $1.72 and as low as $1.60, and closed at $1.60. Trading volume was a total of 7.40K shares. On August 02, 2017, KBIO opened at $1.59, traded as high as $1.72 and as low as $1.57, and closed at $1.72. Trading volume was a total of 10.30K shares. On August 03, 2017, KBIO opened at $1.61, traded as high as $1.75 and as low as $1.61, and closed at $1.73. Trading volume was a total of 23.10K shares. On August 04, 2017, KBIO opened at $1.60, traded as high as $2.20 and as low as $1.60, and closed at $2.19. Trading volume was a total of 30.00K shares.

KBIO Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into KBIO shares, starting with a $10,000 purchase of KBIO, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	04/22/2014
End date:	08/04/2017
Start price/share:	$20.96
End price/share:	$2.19
Dividends collected/share:	$0.00
Total return:	-89.55%
Average Annual Total Return:	-49.69%
Starting investment:	$10,000.00
Ending investment:	$1,045.05
Years:	3.29

KBIO Historical Price Range
Date	Open	High	Low	Close	Volume
07/31/2017	$1.60	$1.75	$1.60	$1.74	7.60K
08/01/2017	$1.60	$1.72	$1.60	$1.60	7.40K
08/02/2017	$1.59	$1.72	$1.57	$1.72	10.30K
08/03/2017	$1.61	$1.75	$1.61	$1.73	23.10K
08/04/2017	$1.60	$2.20	$1.60	$2.19	30.00K

About KBIO

Kalobios Pharmaceuticals is a biopharmaceutical company focused on the development of monoclonal antibody therapeutics. Using Co.'s Humaneered® antibody technology, Co. has produced a portfolio of antibodies to treat medical conditions with a primary clinical focus on respiratory diseases and cancer. Co. has developed three monoclonal antibodies to the clinical development stage: KB004, which is a Humaneered® anti-EphA3 monoclonal antibody; KB003, which is a Humaneered® anti-granulocyte macrophage colony-stimulating factor monoclonal antibody; and KB001-A, which is a Humaneered® developed for the prevention and treatment of Pseudomonas aeruginosa infections.

KBIO Historical Closing Prices
Date	Close
07/31/2017	$1.74
08/01/2017	$1.60
08/02/2017	$1.72
08/03/2017	$1.73
08/04/2017	$2.19

Healthcare Historical Prices

KBIO is categorized under the Healthcare sector; below are some other companies in the same sector: KBLM Historical Stock Prices KDMN Historical Stock Prices KEQU Historical Stock Prices KERX Historical Stock Prices KIDS Historical Stock Prices KIN Historical Stock Prices KIPS Historical Stock Prices KITE Historical Stock Prices KMPH Historical Stock Prices KND Historical Stock Prices Free KBIO Email Alerts: Get Dividend Alerts Get SEC Filing Alerts

KBIO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.